Akt3 siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemAkt3 siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-38911
Quantity10 µM
Gene Namev-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)
Specieshuman
TypesiRNA/dsRNA
NCBI Full Gene NameAKT serine/threonine kinase 3
NCBI Gene AliasesMPPH, MPPH2, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma, RAC-gamma, STK-2

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) AKT activation triggers Rab14-mediated ADAM10 translocation to the cell surface in human aortic endothelial cellsSci RepMarch 3, 2025Chung Hee Baek, Hyosang Kim, Soo Young Moon, Eun Kyoung Lee, Won Seok Yang(Ambion®) were from ThermoFisher Scientific. AKT1-siRNA (sc-29195), AKT2-siRNA (sc-29197), AKT3-siRNA (sc-38911), and the corresponding control siRNA (sc-37007) were from Santa Cruz Biotechnology, Inc. Cell culture Primary

(2) Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutationsScientific reportsAugust 1, 2017Rao G, Pierobon M, Kim IK, Hsu WH, Deng J, Moon YW, Petricoin EF, Zhang YW, Wang Y, Giaccone G.CAAGGGCACTTTCGGCAAG (siRNA #2), and TCACAGCCCTGAAGTACTC (siRNA #3). AKT2 siRNAs (sc-29197), AKT3 siRNA (sc-38911) and MARCKS siRNAs (sc-35857) were purchased from Santa Cruz. Western blotting Cell lysates were extracted

(4) Functional Effects of AKT3 on Aurora Kinase Inhibitor-induced AneuploidyThe Journal of biological chemistryFebruary 3, 2017Noguchi K, Hongama K, Hariki S, Nonomiya Y, Katayama K, Sugimoto Y.

(6) AKT3 controls mitochondrial biogenesis and autophagy via regulation of the major nuclear export protein CRM-1FASEB journal : official publication of the Federation of American Societies for Experimental BiologyJanuary 1, 2014Corum DG, Tsichlis PN, Muise-Helmericks RC.

(7) Regulation of inflammatory breast cancer cell invasion through Akt1/PKBα phosphorylation of RhoC GTPaseMolecular cancer research : MCROctober 1, 2012Lehman HL, Van Laere SJ, van Golen CM, Vermeulen PB, Dirix LY, van Golen KL.

(8) Inhibition of HSP27 alone or in combination with pAKT inhibition as therapeutic approaches to target SPARC-induced glioma cell survivalMolecular cancerApril 5, 2012Schultz CR, Golembieski WA, King DA, Brown SL, Brodie C, Rempel SA.Santa Cruz Biotechnology (Santa Cruz, CA) SPARC siRNA (sc-37166), AKT1/2 siRNA (sc-43609), and AKT3 siRNA (sc-38911). Antibodies: Haematologic Technologies (Essex Junction, VT): SPARC (AON-5031). Cell Signaling Technology

(9) Expression of matrix metalloproteinase-13 is controlled by IL-13 via PI3K/Akt3 and PKC-δ in normal human dermal fibroblastsThe Journal of investigative dermatologyMarch 1, 2011Moriya C, Jinnin M, Yamane K, Maruo K, Muchemwa FC, Igata T, Makino T, Fukushima S, Ihn H.

(11) Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2The Journal of biological chemistryDecember 12, 2008Toschi A, Lee E, Gadir N, Ohh M, Foster DA.

Akt3 siRNA (h)